Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
TG Therapeutics, Inc. (TGTX) had Return on Equity of 64.37% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$161.71M |
|
$390.89M |
|
$28.09M |
|
$133.62M |
|
$132.34M |
|
$29.36M |
|
$-3.46M |
|
$25.91M |
|
$25.91M |
|
$390.89M |
|
$390.89M |
|
$390.89M |
|
$390.89M |
|
$29.36M |
|
$28.95M |
|
145.42M |
|
161.00M |
|
$2.69 |
|
$2.43 |
|
| Balance Sheet Financials | |
$599.76M |
|
-- |
|
$425.26M |
|
$1.03B |
|
$156.81M |
|
$245.34M |
|
$261.00M |
|
$417.81M |
|
$607.22M |
|
$607.22M |
|
$607.22M |
|
155.21M |
|
| Cash Flow Statement Financials | |
$-44.43M |
|
$29.44M |
|
$-90.79M |
|
$181.19M |
|
$75.41M |
|
$-105.78M |
|
$49.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.82 |
|
-- |
|
-- |
|
0.29 |
|
0.40 |
|
82.63% |
|
18.16% |
|
18.16% |
|
-- |
|
16.02% |
|
241.73% |
|
$-44.58M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.19 |
|
0.61 |
|
147.70 |
|
|
Return on Equity |
64.37% |
64.37% |
|
38.14% |
|
45.85% |
|
$3.91 |
|
$-0.28 |
|
$-0.28 |
|